Eloise Hudry

Company: Novartis AG

Job title: Director - Head of Investigative Translational Toxicology

Seminars:

Roundtable Discussion: Identifying Biomarkers & Endpoints in Slowly Progressing Neurodegenerative Diseases to Predict Disease Progression & Improve Patient Targeting 10:00 am

Exploring emerging fluid and imaging biomarkers to get a better understanding of progressing neurodegenerative diseases Discussing what endpoints are important to better understand disease progression Analyzing the difficulty in understanding disease progression and its effects on clinical and preclinical trialsRead more

day: Conference Day Two